Myomo, Inc. MYO
1.23 USD +0.04 (+3.36%)
Nov 6, 2026, 3:59 PM EST
1.19 Day range 1.23
0.605 52-week range 1.89
- YTD
- +35.16%
- 1 year
- +50.55%
News
businesswire.com Myomo to Attend the 17th Annual Craig Hallum Alpha Select Conference BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from…
businesswire.com Myomo to Report Third Quarter 2026 Financial Results on November 9 BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from…
benzinga.com Myomo Q2 2026 Earnings Call Transcript Myomo (AMEX:MYO) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time…
benzinga.com Ascendiant Capital Maintains Buy on Myomo, Raises Price Target to $10.5 Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and raises the price target from $10 to $10.5.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday's regular session. The company's market cap stands at $4.3 million. Ensysce Biosciences (NASDAQ:ENSC)…- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday's after-market session. The company's market cap stands at $4.2 million. Caris Life Sciences…
benzinga.com Myomo Raises FY2026 Sales Guidance from $43.000M-$46.000M to $45.000M-$47.000M vs $44.434M Est Myomo (AMEX:MYO) raises FY2026 sales outlook from $43.000 million-$46.000 million to $45.000 million-$47.000 million vs $44.434 million estimate.- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com Ascendiant Capital Maintains Buy on Myomo, Raises Price Target to $10 Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and raises the price target from $9.5 to $10.
benzinga.com Myomo Affirms FY2026 Sales Guidance of $43.000M-$46.000M vs $48.591M Est Myomo (AMEX:MYO) affirms FY2026 sales outlook from $43.000 million-$46.000 million to $43.000 million-$46.000 million vs $48.591 million estimate.
benzinga.com Myomo Q1 EPS $(0.07) Beats $(0.08) Estimate, Sales $10.113M Miss $10.486M Estimate Myomo (AMEX:MYO) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 12.5 percent increase over losses of $(0.08) per share…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session - benzinga.com Myomo Signs Agreement With Elevance Health Over Commercial, Medicare Advantage, Medicaid Plans; Expand Myomo's MyoPro Powered Arm And Hand Orthoses Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,…
benzinga.com Earnings Breakdown: Myomo Q4 
benzinga.com Myomo Q4 EPS $(0.09) Misses $(0.04) Estimate, Sales $11.353M Miss $11.556M Estimate Myomo (AMEX:MYO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.04) by 104.55 percent. This is a 800 percent decrease over losses of $(0.01) per…
benzinga.com Earnings Scheduled For March 9, 2026 
benzinga.com Preview: Myomo's Earnings - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com Alpha Buying: Value With a Catalyst Attached - benzinga.com Myomo Affirms FY2025 Sales Guidance of $40.000M-$42.000M vs $40.188M Est Myomo (AMEX:MYO) affirms FY2025 sales outlook from $40.000 million-$42.000 million to $40.000 million-$42.000 million vs $40.188 million estimate.
- benzinga.com Myomo Q3 EPS $(0.09), Inline, Sales $10.091M Beat $9.438M Estimate Myomo (AMEX:MYO) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. This is a 200 percent decrease over losses of $(0.03) per share from the same period last…
benzinga.com Earnings Scheduled For November 10, 2025 - benzinga.com A Peek at Myomo's Future Earnings
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com Ascendiant Capital Maintains Buy on Myomo, Lowers Price Target to $10.5 Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and lowers the price target from $11.5 to $10.5.
benzinga.com Crude Oil Down 1%; Gevo Shares Spike Higher U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 1% on Tuesday. The Dow traded up 1.04% to 44,431.01 while the NASDAQ rose 1.26% to 21,654.94. The S&P 500 also…
benzinga.com Dow Surges 500 Points; US Core Inflation Rises To 3.1% U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 1% on Tuesday. The Dow traded up 1.14% to 44,477.20 while the NASDAQ rose 1.28% to 21,659.58. The S&P 500…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session - benzinga.com HC Wainwright & Co. Maintains Buy on Myomo, Lowers Price Target to $5 HC Wainwright & Co. analyst Sean Lee maintains Myomo (AMEX:MYO) with a Buy and lowers the price target from $9.5 to $5.
benzinga.com Myomo Shares Plunge Over 42% Pre-Market Despite Q2 Revenue Beat Amid Weak Outlook, Rising Losses Myomo's stock dropped over 42% during pre-market trading despite beating second-quarter revenue expectations.- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com Myomo Lowers FY2025 Sales Guidance from $50.000M-$53.000M to $40.000M-$42.000M vs $49.208M Est Myomo (AMEX:MYO) lowers FY2025 sales outlook from $50.000 million-$53.000 million to $40.000 million-$42.000 million vs $49.208 million estimate.
- benzinga.com Myomo Q2 EPS $(0.11), Inline, Sales $9.652M Beat $9.147M Estimate Myomo (AMEX:MYO) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 266.67 percent decrease over losses of $(0.03) per share from the same period last…
- benzinga.com Earnings Scheduled For August 11, 2025
benzinga.com Insights Ahead: Myomo's Quarterly Earnings - benzinga.com Craig-Hallum Maintains Buy on Myomo, Lowers Price Target to $8 Craig-Hallum analyst Craig Knickerbocker maintains Myomo (AMEX:MYO) with a Buy and lowers the price target from $10 to $8.
- benzinga.com Myomo Sets Financial Goals Targeting $100M Annual Revenue By 2028 With 70-72% Gross Margin, 15-20% EBITDA Margin, And Cash Flow Breakeven At $17M-18M Quarterly Revenue Management will present a long-range financial model, with the goal of $100 million in annual revenue by 2028. Elements of the aspirational model to be discussed include:$15 million of annual…
- benzinga.com Deep Dive Into Myomo Stock: Analyst Perspectives (5 Ratings)
- benzinga.com Ascendiant Capital Maintains Buy on Myomo, Raises Price Target to $11.5 Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and raises the price target from $11 to $11.5.
- benzinga.com Craig-Hallum Maintains Buy on Myomo, Lowers Price Target to $10 Craig-Hallum analyst Craig Knickerbocker maintains Myomo (AMEX:MYO) with a Buy and lowers the price target from $11 to $10.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session - benzinga.com CORRECTION: Myomo Q1 EPS $(0.08) Misses $(0.06) Estimate, Sales $9.83M Miss $10.91M Estimate Myomo (AMEX:MYO) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 20 percent increase over losses of $(0.10) per share…
- benzinga.com Myomo Affirms FY2025 Sales Guidance of $50.00M-$53.00M vs $61.78M Est Myomo (AMEX:MYO) affirms FY2025 sales outlook from $50.00 million-$53.00 million to $50.00 million-$53.00 million vs $61.78 million estimate.
- benzinga.com Earnings Scheduled For May 7, 2025
- benzinga.com Earnings Scheduled For March 10, 2025
- benzinga.com Nvidia To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- benzinga.com Earnings Scheduled For March 7, 2024 Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.